đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to evaluate the safety and efficacy of Obinutu...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2021-11-17
Trial ID
NCT04983888
Treatments Being Tested
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen BrĂŒder Graz - Abteilung FĂŒr Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
The goal of this clinical trial is to learn the efficacy and safety of zanu...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-01
Trial ID
NCT06959732
Treatments Being Tested
Background: Chronic Lymphocytic Leukemia (CLL) is the most common leukemia ...
Status
Completed
Location
Grupo Cooperativo de HemopatĂas Malignas
Start Date
2018-12-01
Trial ID
NCT03755947
Treatments Being Tested
This study aims to observe and explore the efficacy and safety of obinutuzu...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-01
Trial ID
NCT05899621
Treatments Being Tested
This study will evaluate the efficacy and safety of venetoclax and obinutuz...
Status
Completed
Location
Medical Center of Aurora
Start Date
2020-05-28
Trial ID
NCT04285567
Treatments Being Tested
This study will evaluate the safety, efficacy, pharmacokinetics and immunog...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-12-31
Trial ID
NCT02631577
Treatments Being Tested
This Phase 1/2, multicenter, open-label study to evaluate CC-220 alone, as ...
Status
Terminated
Location
Local Institution - 106
Start Date
2020-11-11
Trial ID
NCT04464798
Treatments Being Tested
Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficac...
Status
Recruiting
Location
BRCR Medical Center
Start Date
2024-04-23
Trial ID
NCT06351527
Treatments Being Tested
This study is a multicenter phase II trial which primary objective is to as...
Status
Completed
Location
CHU d'Angers
Start Date
2018-02-12
Trial ID
NCT03276468
Treatments Being Tested